"randomised, multicentre, double-blind, placebo-controlledstudy of ambrisentan in subjects with inoperable chronicthromboembolic pulmonary hypertension (CTEPH)"
2020-07-04
عنوان الدراسة
"randomised, multicentre, double-blind, placebo-controlledstudy of ambrisentan in subjects with inoperable chronicthromboembolic pulmonary hypertension (CTEPH)"
داعم الدراسة
GSK
دواء الدراسة
Ambrisentan 5 mg
رقم بروتوكول الدراسة
AMB115811
حالة الدراسة
Terminated
موقع الدراسة
N\A
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.